On Invalid Date, Traws Pharma (NASDAQ: TRAW) reported Q1 2024 earnings per share (EPS) of -$0.24, up 14.29% year over year. Total Traws Pharma earnings for the quarter were -$4.98 million. In the same quarter last year, Traws Pharma's earnings per share (EPS) was -$0.28.
As of Q2 2024, Traws Pharma's earnings has grown year over year. Traws Pharma's earnings in the past year totalled -$18.16 million.
What was TRAW's revenue last quarter?
On Invalid Date, Traws Pharma (NASDAQ: TRAW) reported Q1 2024 revenue of $56.00 thousand up 0% year over year. In the same quarter last year, Traws Pharma's revenue was $56.00 thousand.
What was TRAW's revenue growth in the past year?
As of Q2 2024, Traws Pharma's revenue has grown 0% year over year. This is 83.22 percentage points lower than the US Biotechnology industry revenue growth rate of 83.22%. Traws Pharma's revenue in the past year totalled $226.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.